Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Nickel	O
/	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
Attending:	O
___.	O
Chief	O
Complaint:	O
dyspnea	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
F	O
with	O
PMH	O
of	O
HFpEF,	O
hypertension,	O
CKD,	O
severe	O
AS	O
s/p	O
TAVR,	O
type	O
2	O
diabetes	O
and	O
COPD	O
on	O
2	O
L	O
of	O
oxygen	O
presents	O
with	O
dyspnea.	O
The	O
patient	O
had	O
a	O
recent	O
admission	O
for	O
___	O
to	O
___	O
for	O
gastroenteritis	O
and	O
an	O
E.	O
coli	O
UTI.	B-Urinary_tract_infection
She	O
reports	O
that	O
five	O
days	O
ago	O
she	O
began	O
to	O
have	O
chills	O
and	O
progressive	O
shortness	O
of	O
breath.	O
She	O
also	O
had	O
nasal	O
congestion	O
but	O
no	O
body	O
aches.	O
She	O
has	O
a	O
cough	O
with	O
sputum	O
production	O
but	O
it	O
is	O
at	O
baseline.	O
She	O
has	O
had	O
no	O
sick	O
contacts,	O
leg	O
swelling,	O
body	O
aches,	O
chest	O
pain	O
or	O
abdominal	O
pain.	O
She	O
has	O
had	O
orthopnea	O
but	O
no	O
PND.	O
She	O
has	O
been	O
taking	O
her	O
albuterol	O
nebulizers	O
several	O
times	O
a	O
day	O
in	O
addition	O
to	O
her	O
inhaler	O
BID.	O
Today	O
she	O
increased	O
her	O
home	O
O2	O
from	O
2L	O
to	O
3L,	O
however	O
continued	O
to	O
have	O
dyspnea	O
and	O
called	O
EMS.	O
In	O
terms	O
of	O
her	O
COPD	O
history	O
she	O
has	O
several	O
exacerbations	O
per	O
year	O
but	O
has	O
never	O
been	O
intubated.	O
In	O
the	O
ED,	O
-	O
Initial	O
Vitals:	O
T	O
97.8	O
HR	O
92	O
BP	O
166/63	O
RR	O
30	O
O2	O
sat	O
98%	O
on	O
nebs	O
-	O
Exam:	O
Const:	O
Short	O
of	O
breath	O
Eyes:	O
No	O
conjunctival	O
injection	O
HENT:	O
NCAT,	O
Neck	O
supple	O
without	O
meningismus	O
CV:	O
RRR,	O
Warm,	O
well-perfused	O
extremities	O
RESP:	O
Tachypneic,	O
diffusely	O
wheezy	O
GI:	O
soft,	O
non-tender,	O
non-distended	O
MSK:	O
No	O
gross	O
deformities	O
appreciated.	O
Nonpitting	O
lower	O
extremity	O
edema.	O
Skin:	O
Warm,	O
dry.	O
No	O
rashes	O
Neuro:	O
Alert,	O
Speech	O
fluent.	O
No	O
facial	O
droop.	O
Psych:	O
Appropriate	O
mood	O
and	O
affect.	O
-	O
Labs:	O
VBG	O
7.36/42,	O
lactate	O
1.7,	O
flu	O
negative	O
-	O
Imaging:	O
CXR:	O
Diffuse	O
increased	O
interstitial	O
markings	O
bilaterally	O
suggests	O
mild	O
interstitial	O
edema.	O
Persistent	O
cardiomegaly.	O
-	O
Interventions:	O
80mg	O
IV	O
methylpred	O
Duonebs	O
2mg	O
IV	O
mag	O
1g	O
CTX/500	O
azithro	O
20mg	O
IV	O
Lasix	O
On	O
arrival	O
to	O
the	O
MICU	O
she	O
reports	O
her	O
work	O
of	O
breathing	O
has	O
improved.	O
Past	O
Medical	O
History:	O
Hypertension	O
COPD	O
on	O
2	O
L	O
home	O
O2	O
HFpEF	O
Aortic	O
stenosis	O
status	O
post	O
TAVR	O
Obstructive	O
sleep	O
apnea	O
Type	O
2	O
diabetes	O
Depression/anxiety	O
Chronic	O
kidney	O
disease	O
RIGHT	O
VOCAL	O
CORD	O
POLYP	O
___	O
TAVR	O
___	O
TUBAL	O
LIGATION	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Mother	O
with	O
cirrhosis,	O
father	O
with	O
emphysema	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM	O
========================	O
VS:	O
Afebrile,	O
BP	O
136/61	O
HR	O
88	O
O2	O
Sat	O
93	O
%	O
Bipap	O
___	O
GENERAL:	O
Alert	O
and	O
interactive,	O
BiPAP	O
mask	O
in	O
place	O
HEENT:	O
NCAT.	O
PERRL,	O
EOMI.	O
Sclera	O
anicteric	O
and	O
without	O
injection.	O
MMM.	O
NECK:	O
Difficult	O
to	O
appreciate	O
JVD	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Audible	O
S1	O
and	O
S2.	O
Systolic	O
murmur	O
at	O
RUSB	O
LUNGS:	O
Diffuse,	O
predominantly	O
expiratory	O
wheezing,	O
prolonged	O
expiratory	O
phase	O
BACK:	O
No	O
spinous	O
process	O
tenderness.	O
No	O
CVA	O
tenderness.	O
ABDOMEN:	O
Normal	O
bowels	O
sounds,	O
non	O
distended,	O
non-tender	O
to	O
deep	O
palpation	O
in	O
all	O
four	O
quadrants.	O
No	O
organomegaly.	O
EXTREMITIES:	O
No	O
clubbing,	O
cyanosis,	O
or	O
edema.	O
NEUROLOGIC:	O
Moving	O
extremities	O
with	O
purpose	O
AOx3.	B-Delirium
DISCHARGE	O
PHYSICAL	O
EXAM	O
========================	O
VS:	O
24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
1222)	O
Temp:	O
97.7	O
(Tm	O
97.9),	O
BP:	O
145/71	O
(125-145/61-72),	O
HR:	O
97	O
(88-107),	O
RR:	O
20	O
(___),	O
O2	O
sat:	O
93%	O
(90-95),	O
O2	O
delivery:	O
2L	O
NC	O
(2L	O
NC-3L),	O
Wt:	O
191.9	O
lb/87.05	O
kg	O
GEN:	O
Elderly	O
female	O
sitting	O
up	O
in	O
chair,	O
no	O
acute	O
distress	O
HEENT:	O
MMM,	O
NC	O
in	O
place	O
CV:	O
RRR,	O
no	O
murmurs	O
or	O
gallops	O
RESP:	O
Moving	O
air	O
well	O
bilaterally,	O
no	O
appreciated	O
wheezes	O
or	O
rales,	O
no	O
increased	O
work	O
of	O
breathing.	O
ABD:	O
mildly	O
distended/obese,	O
NTTP,	O
BS	O
present	O
GU:	O
no	O
foley	O
EXTR:	O
no	O
edema,	O
no	O
rashes	O
or	O
wounds	O
Psych:	O
alert,	O
appropriate,	O
very	O
pleasant	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
===============	O
___	O
07:43PM	O
BLOOD	O
WBC-3.9*	O
RBC-3.09*	O
Hgb-9.0*	O
Hct-29.4*	O
MCV-95	O
MCH-29.1	O
MCHC-30.6*	O
RDW-16.7*	O
RDWSD-58.3*	O
Plt	O
___	O
___	O
07:43PM	O
BLOOD	O
Neuts-67.1	O
___	O
Monos-10.2	O
Eos-2.0	O
Baso-0.0	O
Im	O
___	O
AbsNeut-2.63	O
AbsLymp-0.80*	O
AbsMono-0.40	O
AbsEos-0.08	O
AbsBaso-0.00*	O
___	O
07:43PM	O
BLOOD	O
Glucose-158*	O
UreaN-22*	O
Creat-1.4*	O
Na-138	O
K-4.3	O
Cl-105	O
HCO3-21*	O
AnGap-12	O
___	O
07:43PM	O
BLOOD	O
ALT-24	O
AST-28	O
AlkPhos-99	O
TotBili-0.3	O
___	O
07:43PM	O
BLOOD	O
Albumin-4.0	O
Calcium-8.4	O
Phos-2.7	O
Mg-1.7	O
___	O
07:48PM	O
BLOOD	O
___	O
pO2-39*	O
pCO2-42	O
pH-7.36	O
calTCO2-25	O
Base	O
XS--1	O
PERTINENT	O
LABS/MICRO:	O
=====================	O
___	O
07:43PM	O
BLOOD	O
D-Dimer-920	O
___	O
06:10AM	O
BLOOD	O
D-Dimer-1170*	O
___	O
03:22PM	O
BLOOD	O
___	O
pO2-177*	O
pCO2-47*	O
pH-7.39	O
calTCO2-30	O
Base	O
XS-3	O
Comment-GREEN	O
TOP	O
___	O
07:43PM	O
BLOOD	O
proBNP-757*	O
___	O
03:14AM	O
BLOOD	O
proBNP-1455*	O
___	O
03:56AM	O
BLOOD	O
___	O
pO2-50*	O
pCO2-49*	O
pH-7.29*	O
calTCO2-25	O
Base	O
XS--3	O
___	O
04:36PM	O
BLOOD	O
___	O
pO2-69*	O
pCO2-48*	O
pH-7.31*	O
calTCO2-25	O
Base	O
XS--2	O
___	O
10:07PM	O
BLOOD	O
___	O
Temp-36.6	O
Rates-/___	O
O2	O
Flow-5	O
pO2-56*	O
pCO2-42	O
pH-7.36	O
calTCO2-25	O
Base	O
XS--1	O
Intubat-NOT	O
INTUBA	O
___	O
03:28AM	O
BLOOD	O
___	O
Temp-36.6	O
pO2-111*	O
pCO2-54*	O
pH-7.27*	O
calTCO2-26	O
Base	O
XS--2	O
Intubat-NOT	O
INTUBA	O
___	O
07:27PM	O
OTHER	O
BODY	O
FLUID	O
FluAPCR-NEG	O
FluBPCR-NEG	O
___	O
07:55PM	O
OTHER	O
BODY	O
FLUID	O
FluAPCR-NEG	O
FluBPCR-NEG	O
___	O
BCx:	O
NGTD	O
___	O
UCx:	O
No	O
growth	O
___	O
Resp	O
viral	O
panel:	O
Negative	O
___	O
Sputum	O
culture:	O
canceled	O
DISCHARGE	O
LABS:	O
===============	O
___	O
06:05AM	O
BLOOD	O
WBC-10.6*	O
RBC-3.21*	O
Hgb-9.0*	O
Hct-29.9*	O
MCV-93	O
MCH-28.0	O
MCHC-30.1*	O
RDW-16.4*	O
RDWSD-55.9*	O
Plt	O
___	O
___	O
06:05AM	O
BLOOD	O
___	O
PTT-50.5*	O
___	O
___	O
06:05AM	O
BLOOD	O
Glucose-153*	O
UreaN-40*	O
Creat-1.3*	O
Na-145	O
K-4.6	O
Cl-102	O
HCO3-30	O
AnGap-13	O
___	O
06:05AM	O
BLOOD	O
Calcium-9.3	O
Phos-3.8	O
Mg-2.0	O
PERTINENT	O
IMAGING:	O
==================	O
___	O
CXR:	O
COPD.	O
Diffuse	O
increased	O
interstitial	O
markings	O
bilaterally	O
suggests	O
mild	O
interstitial	O
edema.	O
Persistent	O
cardiomegaly.	O
___	O
CXR:	O
In	O
comparison	O
with	O
the	O
study	O
of	O
___,	O
there	O
again	O
is	O
hyperexpansion	O
of	O
the	O
lungs	O
with	O
flattening	O
hemidiaphragms	O
consistent	O
with	O
chronic	O
pulmonary	O
disease.	O
Stable	O
enlargement	O
of	O
the	O
cardiac	O
silhouette	O
with	O
increasing	O
pulmonary	O
edema.	O
Probable	O
small	O
bilateral	O
pleural	O
effusions.	O
Specifically,	O
no	O
evidence	O
of	O
pneumothorax.	O
___	O
CXR:	O
IMPRESSION:	O
Heart	O
size	O
and	O
mediastinum	O
are	O
overall	O
stable	O
in	O
appearance.	O
Bibasal	O
opacities	O
are	O
minimal,	O
unchanged	O
since	O
___	O
with	O
no	O
evidence	O
of	O
progression	O
or	O
consolidations	O
or	O
development	O
of	O
pulmonary	O
edema.	O
No	O
pleural	O
effusion	O
or	O
pneumothorax.	O
___	O
V/Q	O
Scan:	O
Low	O
likelihood	O
ratio	O
for	O
acute	O
pulmonary	O
thromboembolism.	O
Brief	O
Hospital	O
Course:	O
___	O
y/o	O
F	O
with	O
PMH	O
of	O
diastolic	O
CHF,	O
hypertension,	O
CKD	O
stage	O
II,	O
severe	O
AS	O
s/p	O
TAVR,	O
DMII,	O
ongoing	O
tobacco	O
use	O
and	O
mod-severe	O
COPD	O
on	O
2	O
L	O
of	O
oxygen	O
presents	O
with	O
acute	O
resp	O
failure	O
secondary	O
to	O
COPD	O
exacerbation.	O
Hospital	O
course	O
was	O
complicated	O
by	O
acute	O
diastolic	O
CHF	O
v	O
flash	O
pulmonary	O
edema,	O
now	O
improving	O
and	O
awaiting	O
dispo	O
evaluation.	O
#Acute	O
on	O
chronic	O
hypoxemic	O
respiratory	O
failure	O
#COPD	O
exacerbation	O
and	O
Acute	O
Diastolic	O
CHF	O
#Chronic	O
tobacco	O
use	O
Mod-Severe	O
COPD	O
with	O
last	O
PFTs	O
in	O
___	O
->	O
FEV1	O
50%	O
predicted,	O
2L	O
NC	O
at	O
home	O
and	O
active	O
smoker	O
at	O
baseline.	O
She	O
was	O
initially	O
admitted	O
to	O
the	O
ICU	O
for	O
BiPAP	O
therapy	O
and	O
was	O
slow	O
to	O
improve	O
despite	O
steroids,	O
nebs	O
and	O
azithromycin.	O
Hospital	O
course	O
was	O
complicated	O
by	O
flash	O
pulm	O
edema/CHF	O
exacerbation	O
while	O
in	O
the	O
ICU	O
improved	O
with	O
diuresis	O
(notable	O
BNP	O
increase	O
compared	O
to	O
admission).	O
Overall,	O
patient's	O
clinical	O
presentation	O
is	O
most	O
consistent	O
with	O
primary	O
COPD	O
exacerbation	O
and	O
mild	O
fluid	O
overload.	O
She	O
was	O
diuresed	O
to	O
euvolemia.	O
Notably,	O
she	O
remained	O
deconditioned	O
with	O
oxygen	O
requirement	O
going	O
up	O
to	O
4L	O
NC	O
with	O
ambulation	O
and	O
very	O
low	O
exercise	O
tolerance.	O
Patient	O
triggered	O
on	O
___	O
for	O
hypoxia	O
to	O
82%	O
on	O
4L	O
and	O
tachycardia	O
likely	O
due	O
to	O
overexertion	O
though	O
worsening	O
COPD	O
v	O
PE	O
on	O
differential;	O
notably	O
lungs	O
without	O
edema,	O
VBG	O
normal.	O
V/Q	O
scan	O
performed	O
and	O
negative.	O
Patient	O
improved	O
slowly	O
clinically	O
and	O
did	O
not	O
have	O
any	O
other	O
concerning	O
episodes	O
thereafter.	O
She	O
was	O
given	O
round-the-clock	O
duonebs,	O
albuterol	O
nebs	O
prn,	O
Advair	O
(to	O
replace	O
home	O
symbicort	O
which	O
is	O
not	O
on	O
formulary	O
here).	O
She	O
was	O
started	O
on	O
steroid	O
taper,	O
decreased	O
to	O
50	O
mg	O
x5	O
days	O
(___),	O
plan	O
to	O
decrease	O
to	O
40	O
mg	O
x5d	O
on	O
___,	O
then	O
30	O
mg	O
x5d,	O
then	O
20mg	O
x5d,	O
then	O
15mg	O
x5d,	O
10	O
mg	O
x5d,	O
5	O
mg	O
x5d	O
then	O
stop.	O
She	O
was	O
continued	O
on	O
GI	O
prophylaxis	O
with	O
pantoprazole.	O
Patient	O
was	O
counseled	O
re:	O
smoking	O
cessation.	O
She	O
was	O
offered	O
nicotine	O
supplementation	O
in-house,	O
which	O
she	O
declined.	O
She	O
expressed	O
understanding	O
regarding	O
the	O
need	O
to	O
quit	O
but	O
declined	O
any	O
further	O
support.	O
#Acute	O
on	O
Chronic	O
HFpEF:	O
Mild	O
exacerbation	O
on	O
admission.	O
On	O
___	O
am	O
patient	O
developed	O
acute	O
hypertension/tachycardia	O
and	O
respiratory	O
distress	O
that	O
was	O
likely	O
___	O
flash	O
pulmonary	O
edema.	O
Pt	O
was	O
treated	O
with	O
diuresis	O
and	O
became	O
clinically	O
euvolemic.	O
Creatinine	O
elevated	O
with	O
___	O
on	O
CKD,	O
improved	O
with	O
a	O
break	O
from	O
diuresis.	O
She	O
was	O
restarted	O
on	O
home	O
Lasix	O
40mg	O
daily	O
but	O
appeared	O
dry	O
as	O
a	O
result	O
thus	O
dose	O
was	O
reduced	O
to	O
20	O
mg	O
at	O
discharge.	O
Home	O
lisinopril	O
was	O
held	O
as	O
patient	O
was	O
normotensive,	O
restarted	O
on	O
discharge.	O
#Acute	O
on	O
chronic	O
CKD:	O
Baseline	O
Creat	O
1.3,	O
peak	O
1.6	O
here	O
likely	O
secondary	O
to	O
diuresis.	O
Patient	O
clinically	O
dry.	O
Was	O
given	O
a	O
break	O
from	O
diuresis	O
and	O
lisinopril	O
was	O
held	O
for	O
part	O
of	O
hospitalization,	O
with	O
normalization	O
of	O
creatinine	O
to	O
baseline.	O
Home	O
meds	O
restarted	O
on	O
discharge	O
per	O
above.	O
#T2DM:	O
Metformin	O
held	O
given	O
___.	O
Patient	O
was	O
started	O
on	O
lantus	O
standing,	O
Humalog	O
standing	O
and	O
sliding	O
scale	O
due	O
to	O
persistent	O
hyperglycemia	O
from	O
steroid	O
use.	O
On	O
day	O
of	O
discharge,	O
regimen	O
was	O
lantus	O
10u	O
qhs,	O
standing	O
Humalog	O
10u	O
with	O
meals	O
and	O
SSI.	O
Doses	O
decreased	O
on	O
discharge	O
given	O
dose	O
decrease	O
of	O
prednisone	O
starting	O
tomorrow	O
and	O
restarting	O
of	O
metformin.	O
#Depression/Anxiety:	O
Likely	O
worsened	O
by	O
admission	O
and	O
dyspnea.	O
Continued	O
citalopram	O
and	O
bupropion	O
#OSA:	O
continued	O
CPAP	O
at	O
night	O
TRANSITIONAL	O
ISSUES:	O
[]	O
please	O
check	O
weekly	O
chem-7	O
and	O
monitor	O
Cr	O
and	O
electrolytes	O
[]	O
Lasix	O
dose	O
decreased	O
on	O
discharge	O
to	O
20	O
mg.	O
Home	O
dose	O
is	O
40mg,	O
increase	O
as	O
needed	O
if	O
showing	O
signs	O
of	O
fluid	O
accumulation.	O
[]	O
hyperglycemia	O
in	O
setting	O
of	O
steroid	O
use.	O
She	O
was	O
started	O
on	O
lantus	O
and	O
Humalog	O
since	O
metformin	O
was	O
held	O
in	O
setting	O
of	O
___.	O
Metformin	O
restarted	O
on	O
discharge	O
and	O
doses	O
of	O
insulin	O
on	O
discharge	O
decreased	O
to	O
reflect	O
decreasing	O
prednisone	O
and	O
resumption	O
of	O
metformin.	O
However,	O
please	O
continue	O
to	O
monitor	O
and	O
adjust	O
insulin	O
as	O
needed.	O
[]	O
prednisone	O
taper:	O
40mg	O
x5d	O
___	O
30mg	O
x5d	O
___	O
20mg	O
x5d	O
___	O
15mg	O
x5d	O
___	O
10mg	O
x5d	O
___	O
5mg	O
x5d	O
___	O
#CODE	O
STATUS:	O
Full	O
code	O
(confirmed)	O
#CONTACT/HCP:	O
___	O
(daughter)	O
___	O
[x]	O
I	O
spent	O
45	O
min	O
in	O
discharge	O
planning	O
and	O
coordination	O
of	O
care	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
3.	O
Azithromycin	O
250	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
4.	O
BuPROPion	O
150	O
mg	O
PO	O
BID	O
5.	O
Citalopram	O
20	O
mg	O
PO	O
DAILY	O
6.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
7.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
8.	O
Lisinopril	O
30	O
mg	O
PO	O
DAILY	O
9.	O
Symbicort	O
(budesonide-formoterol)	O
160-4.5	O
mcg/actuation	O
inhalation	O
BID	O
10.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
11.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
sob	O
12.	O
Furosemide	O
40	O
mg	O
PO	O
DAILY	O
13.	O
MetFORMIN	O
(Glucophage)	O
850	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
2	O
NEB	O
IH	O
Q2H:PRN	O
wheezing/SOB	O
2.	O
Bisacodyl	O
10	O
mg	O
PO/PR	O
DAILY:PRN	O
Constipation	O
-	O
Second	O
Line	O
3.	O
Dextrose	O
50%	O
12.5	O
gm	O
IV	O
PRN	O
hypoglycemia	O
protocol	O
4.	O
Glucagon	O
1	O
mg	O
IM	O
Q15MIN:PRN	O
hypoglycemia	O
protocol	O
5.	O
Glucose	O
Gel	O
15	O
g	O
PO	O
PRN	O
hypoglycemia	O
protocol	O
6.	O
Glargine	O
10	O
Units	O
Bedtime	O
Humalog	O
6	O
Units	O
Breakfast	O
Humalog	O
6	O
Units	O
Lunch	O
Humalog	O
6	O
Units	O
Dinner	O
Humalog	O
2	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
7.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
8.	O
PredniSONE	O
15	O
mg	O
PO	O
DAILY	O
Duration:	O
5	O
Doses	O
Start:	O
After	O
20	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
4	O
of	O
6	O
tapered	O
doses	O
9.	O
PredniSONE	O
10	O
mg	O
PO	O
DAILY	O
Duration:	O
5	O
Doses	O
Start:	O
After	O
15	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
5	O
of	O
6	O
tapered	O
doses	O
10.	O
PredniSONE	O
5	O
mg	O
PO	O
DAILY	O
Duration:	O
5	O
Doses	O
Start:	O
After	O
10	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
6	O
of	O
6	O
tapered	O
doses	O
11.	O
PredniSONE	O
40	O
mg	O
PO	O
DAILY	O
Duration:	O
5	O
Doses	O
Start:	O
Tomorrow	O
-	O
___,	O
First	O
Dose:	O
First	O
Routine	O
Administration	O
Time	O
This	O
is	O
dose	O
#	O
1	O
of	O
6	O
tapered	O
doses	O
12.	O
PredniSONE	O
30	O
mg	O
PO	O
DAILY	O
Duration:	O
5	O
Doses	O
Start:	O
After	O
40	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
2	O
of	O
6	O
tapered	O
doses	O
13.	O
PredniSONE	O
20	O
mg	O
PO	O
DAILY	O
Duration:	O
5	O
Doses	O
Start:	O
After	O
30	O
mg	O
DAILY	O
tapered	O
dose	O
This	O
is	O
dose	O
#	O
3	O
of	O
6	O
tapered	O
doses	O
14.	O
Ramelteon	O
8	O
mg	O
PO	O
QPM:PRN	O
insomnia	O
15.	O
Senna	O
17.2	O
mg	O
PO	O
BID:PRN	O
Constipation	B-Constipation
-	O
First	O
Line	O
16.	O
Sodium	O
Chloride	O
Nasal	O
___	O
SPRY	O
NU	O
QID:PRN	O
congestion	O
17.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
18.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
sob	O
19.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
20.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
21.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
22.	O
Azithromycin	O
250	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
23.	O
BuPROPion	O
150	O
mg	O
PO	O
BID	O
24.	O
Citalopram	O
20	O
mg	O
PO	O
DAILY	O
25.	O
Lisinopril	O
30	O
mg	O
PO	O
DAILY	O
26.	O
MetFORMIN	O
(Glucophage)	O
850	O
mg	O
PO	O
BID	O
27.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
28.	O
Symbicort	O
(budesonide-formoterol)	O
160-4.5	O
mcg/actuation	O
inhalation	O
BID	O
29.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
CHRONIC	O
OBSTRUCTIVE	O
PULMONARY	O
DISEASE	O
WITH	O
ACUTE	O
EXACERBATION	O
ACUTE	O
ON	O
CHRONIC	O
HYPOXEMIC	O
RESPIRATORY	O
FAILURE	O
DIASTOLIC	O
HEART	O
FAILURE	O
EXACERBATION	O
ACUTE	O
KIDNEY	O
INJURY	O
CHRONIC	O
KIDNEY	O
DISEASE	O
DIABETES	O
MELLITUS	O
WITH	O
HYPERGLYCEMIA	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	O
requires	O
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
during	O
your	O
hospitalization	O
at	O
___!	O
Why	O
did	O
you	O
come	O
to	O
the	O
hospital?	O
-	O
Because	O
you	O
were	O
having	O
trouble	O
breathing	O
What	O
happened	O
while	O
you	O
were	O
in	O
the	O
hospital?	O
-	O
You	O
were	O
found	O
to	O
have	O
an	O
exacerbation	O
of	O
your	O
COPD.	O
You	O
needed	O
bipap	O
so	O
you	O
were	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
and	O
were	O
treated	O
with	O
the	O
BiPAP,	O
as	O
well	O
as	O
steroids,	O
nebulizers	O
and	O
other	O
supportive	O
therapies	O
-	O
While	O
in	O
the	O
ICU,	O
you	O
also	O
developed	O
fluid	O
overload	O
and	O
received	O
diuresis	O
for	O
it	O
-	O
You	O
came	O
to	O
the	O
regular	O
medical	O
floor	O
where	O
we	O
continued	O
to	O
work	O
on	O
optimizing	O
your	O
breathing	O
-	O
You	O
remained	O
quite	O
deconditioned	O
and	O
short	O
of	O
breath	O
with	O
minimal	O
exertion	O
so	O
you	O
had	O
to	O
go	O
to	O
rehab	O
before	O
going	O
home.	O
What	O
should	O
you	O
do	O
after	O
you	O
leave	O
the	O
hospital?	O
-	O
Please	O
weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
-	O
Continue	O
to	O
take	O
your	O
medications	O
as	O
before.	O
You	O
are	O
on	O
a	O
steroid	O
taper,	O
so	O
tomorrow	O
___	O
you	O
will	O
go	O
down	O
to	O
40	O
mg	O
daily.	O
The	O
doses	O
will	O
continue	O
to	O
decrease	O
every	O
5	O
days	O
until	O
we	O
can	O
stop	O
it.	O
-	O
Follow	O
up	O
with	O
Dr.	O
___	O
in	O
Pulmonary	O
clinic	O
in	O
___	O
___	O
as	O
scheduled	O
-	O
Please	O
continue	O
to	O
abstain	O
from	O
smoking.	O
You	O
told	O
us	O
you	O
did	O
not	O
require	O
any	O
assistance	O
with	O
this,	O
but	O
any	O
of	O
your	O
doctors	O
___	O
be	O
happy	O
to	O
help	O
with	O
nicotine	O
supplementation,	O
Chantix	O
or	O
other	O
medical	O
therapies	O
if	O
you	O
think	O
they	O
will	O
be	O
helpful.	O
We	O
wish	O
you	O
the	O
___!	O
Sincerely,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

